Study Versatope 2020-01: Prophylactic potential of test articles in the hamster infection model of C. difficile disease (HCDAD)

Project Details

StatusFinished
Effective start/end date18/11/20 → 17/11/21

Funding

  • Versatope Therapeutics, Inc.: $64,852.80